PropertyValue
?:abstract
  • The number of patients with acute episodes of severe bronchospasm needing intubation and ventilatory support has increased rapidly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease 2019 (COVID-19) pandemic. Although medical consensus upholds the use of ventilatory support in this pathology, its survival benefits remain unclear. To improve the outcomes and survival rates, a bundle of early respiratory therapy with a pharmacological rescue regimen was provided to four patients with bronchospasm secondary to COVID-19. This therapeutic approach successfully delayed the need for invasive mechanical ventilation for 48 hours and decreased the mortality rate in all cases.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.7759/cureus.10822
?:journal
  • Cureus
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/216c0caa72734974dc5c8caf3c7174bbf2cbc773.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7645293.xml.json
?:pmcid
?:pmid
?:pmid
  • 33173630.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Decreased Mortality in Patients With Severe Bronchospasm Associated With SARS-CoV-2: An Alternative to Invasive Mechanical Ventilation
?:type
?:year
  • 2020-10-06

Metadata

Anon_0  
expand all